Social determinants of health (SDOH) and late mortality among survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).

C Cindy Im F Fang Wang Y Yan Chen C Carrie R. Howell (University of Alabama at Birmingham, Birmingham, AL) K Kristine Karvonen (9Seattle Children's Hospital, Division of Pediatric Hematology-Oncology, Seattle, United States) V Vikki G. Nolan (St. Jude Children's Research Hospital, Memphis, TN) A Aaron J. McDonald L Lucie Marie Turcotte (University of Minnesota, Minneapolis, MN) E Eric Jessen Chow (Fred Hutch Cancer Center, Seattle, WA) Y Yutaka Yasui P Paul C. Nathan C Claire Frances Snyder (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD) G Gregory T. Armstrong I I-Chan Huang (St. Jude Children's Research Hospital, Memphis, TN)

Abstract

10021 Background: Neighborhood-level SDOH may increase disparities in adverse cancer-related outcomes. The US CDC-constructed Social Vulnerability Index (SVI) reflects 4 SDOH domains (socioeconomic status [SES]; household composition; minority status/language; housing/transportation) and captures the vulnerability of underserved communities. The impact of neighborhood-level SDOH on late mortality among survivors of childhood cancer is not known. Methods: Analyses included 5-year survivors in the US diagnosed in 1970-1999 participating in the CCSS, a multi-institutional retrospective cohort study. We evaluated geocoded SVI quintiles (Q1 to Q5, from least to most vulnerable) based on residential addresses and personal SES factors including income, education level, and health insurance status collected at CCSS baseline. The impact of SVI and personal-level SES on all-cause and cause-specific mortality rates were evaluated using cumulative incidence and relative rates (RRs) from piecewise exponential regression models adjusted for age, sex, diagnosis age, and treatments. Results: Among 20,261 survivors with geocode data (mean age at cancer diagnosis and baseline evaluation, 7y and 24y respectively, with a mean follow up of 17y), 2,439 survivors died. All-cause late mortality was greater in survivors living in more vulnerable areas (Q5 vs. Q1, at 20y: 14.7% vs. 10.8%, P<0.001). We observed a dose-response relationship between worsening SVI and the all-cause mortality rate (Q5 vs. Q1 RR 1.52, 95% CI 1.32-1.76, P trend <0.001) as well as for mortality rates due to specific health causes (Table). Among the SDOH domains, neighborhood SES (Q5 vs. Q1 RR 1.68, 95% CI 1.45-1.95) showed the strongest association with all-cause mortality followed by household composition (RR 1.43, 95% CI 1.24-1.66). Notably, these findings remained largely consistent after adjusting for personal-level SES as well as in analyses stratified by income and insurance coverage. Conclusions: Living in socially vulnerable neighborhoods during young adulthood is associated with a ~50% increased risk for late mortality among survivors of childhood cancer and is largely unaffected by favorable personal-level SES. Policies and interventions targeting neighborhood-level SDOH during the transition to survivorship care are needed to reduce mortality risk in this population. Adjusted RRs and 95% confidence intervals for overall and cause-specific mortality. SVI All cause Subsequent neoplasm cause Cardiovascular cause Other health causes Q2 1.00 (0.88 - 1.14) 0.90 (0.74 - 1.11) 1.09 (0.76 - 1.55) 1.09 (0.85 - 1.39) Q3 1.16 (1.02 - 1.32) 1.03 (0.84 - 1.27) 1.18 (0.82 - 1.70) 1.24 (0.97 - 1.59) Q4 1.24 (1.08 - 1.42) 1.12 (0.90 - 1.39) 1.29 (0.88 - 1.90) 1.44 (1.11 - 1.86) Q5 1.52 (1.32 - 1.76) 1.35 (1.07 - 1.69) 1.54 (1.02 - 2.33) 1.83 (1.38 - 2.42) SVI Q1 (least vulnerable) is the referent.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 10021-10021
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (14)

C

Cindy Im

F

Fang Wang

Y

Yan Chen

C

Carrie R. Howell

University of Alabama at Birmingham, Birmingham, AL

K

Kristine Karvonen

9Seattle Children's Hospital, Division of Pediatric Hematology-Oncology, Seattle, United States

V

Vikki G. Nolan

St. Jude Children's Research Hospital, Memphis, TN

A

Aaron J. McDonald

L

Lucie Marie Turcotte

University of Minnesota, Minneapolis, MN

E

Eric Jessen Chow

Fred Hutch Cancer Center, Seattle, WA

Y

Yutaka Yasui

P

Paul C. Nathan

C

Claire Frances Snyder

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD

G

Gregory T. Armstrong

I

I-Chan Huang

St. Jude Children's Research Hospital, Memphis, TN